FSU research: Ketamine could help men suffering from alcohol use disorder

November 19, 2019

Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions.

A team of researchers working in the laboratory of Mohamed Kabbaj, a professor of Biomedical Sciences and Neuroscience in the College of Medicine, showed that ketamine can decrease alcohol consumption in male rats that previously had consumed high amounts of alcohol when given unrestricted access several times a week. The neuroscience journal eNeuro published the research in its November edition.

There are no perfect treatments for alcoholism, Kabbaj said. Many patients relapse within a year after treatment.

"What makes ketamine interesting in our study is that it reduced alcohol intake, and the effect was long-lasting even after we stopped ketamine treatment," he said.

Ketamine is a promising frontier in psychiatric treatment. Existing antidepressants don't work for all patients, so scientists are looking for other effective options. Ketamine is one possibility. In March 2019, the U.S. Food and Drug Administration approved a nasal spray that includes a form of ketamine for use on patients with depression who didn't respond to other treatments.

But doctors still have questions about how ketamine works. This latest research is one piece of a larger investigation by Kabbaj's team to learn more about the drug, specifically its interactions with alcohol, the number one drug abused by depressed patients.

In this study, researchers examined how ketamine affected the rats' alcohol consumption and how that alcohol intake affected their self-administration of ketamine.

The major finding in the study was that high-alcohol intake male rats displayed a significant reduction in alcohol consumption after a regimen of ketamine compared to rats that received a saline solution. The effect lasted for at least three weeks even after stopping ketamine treatment, suggesting a long-term benefit of ketamine in reducing alcohol use.

"Three weeks is a long time in a rat's life," Kabbaj said. "If a similar thing happened in humans, one could imagine that after a short treatment with ketamine, alcoholic patients would cease alcohol intake for a couple of years. That would be a great achievement."

Ketamine didn't affect high-alcohol female rats, and interestingly, it increased drinking in low-alcohol females. Researchers said clinical studies for men and for women are needed before ketamine is used as a therapy for alcoholism in either sex.
-end-
The National Institute of Mental Health and the National Institute on Drug Abuse provided funding for this study.

Florida State University

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.